…"these findings are encouraging because they suggest it may be possible to determine the onset, spread and morphology of AD — a preclinical diagnosis — using retinal imaging, rather than more difficult and costly brain scans,” said senior author Robert Rissman, PhD, professor of neurosciences at UC San Diego School of Medicine.